Open Access
| Numéro |
Med Sci (Paris)
Volume 41, Numéro 1, Janvier 2025
|
|
|---|---|---|
| Page(s) | 9 - 12 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2024187 | |
| Publié en ligne | 31 janvier 2025 | |
- Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med 2020 ; 8 : 1233–44. [CrossRef] [PubMed] [Google Scholar]
- Debray A, Nathanson S, Moulin F, et al. Eosinopenia as a marker of diagnosis and prognostic to distinguish bacterial from aseptic meningitis in pediatrics. Eur J Clin Microbiol Infect Dis 2019 ; 38 : 1821–7. [CrossRef] [PubMed] [Google Scholar]
- Outh R, Boutin C, Gueudet P, et al. Eosinopenia <100/ML as a marker of active COVID-19: an observational prospective study. J Microbiol Immunol Infect 2021 ; 54 : 61–8. [CrossRef] [PubMed] [Google Scholar]
- Davido B, Jaffal K, Saleh-Mghir A, et al. Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic. Front Immunol 2024 ; 15 : 1381059. [CrossRef] [PubMed] [Google Scholar]
- Eijmael M, Janssens N, le Cessie S, et al. Coronavirus disease 2019 and peripheral blood eosinophil counts: A retrospective study. Infection 2021 ; 49 : 1325–9. [CrossRef] [PubMed] [Google Scholar]
- Cauchois R, Pietri L, Dalmas JB, et al. Eosinopenia as predictor of poor outcome in hospitalized COVID-19 adult patients from waves 1 and 2 of 2020 pandemic. Microorganisms 2022 ; 10 : 2423. [CrossRef] [PubMed] [Google Scholar]
- Abidi K, Khoudri I, Belayachi J, et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care 2008 ; 12 : R59. [CrossRef] [PubMed] [Google Scholar]
- Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med 2021 ; 26 : 107–8. [CrossRef] [PubMed] [Google Scholar]
- Nazemi P, SeyedAlinaghi S, Azarnoush A, et al. Serum C-reactive protein greater than 75 mg/dL as an early available laboratory predictor of severe COVID-19: A systematic review. Immun Inflamm Dis 2023 ; 11 : e1130. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.